APOE and STH Gene Variations in Alzheimer's Disease
Author Information
Author(s): Zuo Lingjun, Dyck Christopher H, Luo Xingguang, Kranzler Henry R, Yang Bao-zhu, Gelernter Joel
Primary Institution: Yale University School of Medicine
Hypothesis
The study aimed to elucidate the association between APOE and AD, and between STH and AD.
Conclusion
The study confirmed that the ε4 allele is a dose-response risk factor for AD, while the ε2 allele is a protective factor.
Supporting Evidence
- The ε4 allele was found to significantly increase the risk of Alzheimer's disease.
- The ε2 allele was identified as a protective factor against Alzheimer's disease.
- Genotyping of APOE could provide biological evidence for Alzheimer's disease risk.
- STH variation was not significantly associated with Alzheimer's disease in the sample.
Takeaway
This study looked at how certain genes might affect the risk of getting Alzheimer's disease, finding that one gene increases risk while another can help protect against it.
Methodology
The study genotyped specific polymorphisms in the APOE and STH genes in patients with AD and healthy controls.
Potential Biases
Potential confounding factors such as age, sex, and family history were controlled for, but residual confounding may still exist.
Limitations
The study did not find significant associations for the STH gene, which may limit the generalizability of the findings.
Participant Demographics
The sample included 369 patients with AD and 289 healthy European-Americans, with a mean age of AD patients being 73.6 years.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI for ε4: 1.13–3.05; 95% CI for ε2: 0.13–0.96
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website